EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

How to improve AML outcomes?

Taner Tan, Sinem Civriz Bozdag

Blood Research · 2024-12 · 59 (1)

DOI: 10.1007/s44313-024-00041-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Blood Research, online erschienen am 02.12.2024. Verfasst von Taner Tan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, ͣKoc University Medical School, Istanbul, Turkey. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the intricacies of the pathophysiology and genomic landscape has enhanced the long-term outcomes for patients with acute myeloid leukemia (AML). The identification of novel molecular targets has introduced new therapeutic strategies that attempt to surpass the dominance of the "7 + 3 regimen" established in the 1970s. In 2022, the World Health Organization and International Consensus Classification revised their definitions and approaches to AML, reflecting the current and evolving changes at the molecular level. The guidelines are now grounded in a definition of the disease that emphasizes genetic characteristics. Today, we recognize AML as a genetically diverse disease; a retrospective study identified 5234 driver mutations across 76 genes or genomic regions, with two or more drivers observed in 86% of patients (Papaemmanuil et al., N Engl J Med 374:2209–21, 2016).

Schlagwörter

Stichwörter der Autor:innen

AMLMutationsOutcomeRelapsedTargetedTreatment

Autor:innen und Institutionen

  • Department of Hematology, ͣKoc University Medical School, Istanbul, Turkey.
  • Department of Hematology, ͣKoc University Medical School, Istanbul, Turkey. scivriz@hotmail.com.

Zitieren

APA

Tan, T., & Bozdag, S. C. (2024). How to improve AML outcomes?. Blood Research, 59(1). https://doi.org/10.1007/s44313-024-00041-7

Vancouver

Tan T, Bozdag SC. How to improve AML outcomes?. Blood Research. 2024;59(1). doi:10.1007/s44313-024-00041-7

BibTeX
@article{Tan2024,
  author = {Tan, Taner and Bozdag, Sinem Civriz},
  title = {How to improve AML outcomes?},
  journal = {Blood Research},
  year = {2024},
  volume = {59},
  number = {1},
  doi = {10.1007/s44313-024-00041-7}
}
Kostenlos starten →